Australia's most trusted source of pharma news
Thursday, 09 April 2020
Lost Your Access?
No COVID vax til '21: CSL
Plus its new deal to develop treatment in cows.
Cancer drugs seek expansion
MSAC sub-committee consider tests for Keytruda, Lynparza
COVID drugs trend on social
As interest in the actual virus wanes.
Aust CAR-T readies for COVID
Local treatments underway as Gilead preps for entry.
Rural pharmacies attack CSO
Claim CSO used to fund wholesaler banner groups.
Phebra tests zinc for virus
Melbourne researchers look at injectable mineral.
Pharma crisis crews in action
Companies share details of local pandemic teams.
Novartis' new oncology boss
Neuroscience head moves into top job.
AbbVie drops patent for COVID
Allows Mylan copy of Kaletra in for local trials.
Roche NZ boss returns to Aust
Pharma veteran takes up new leadership role.
Pharma unites in Oz COVID fight
ACCC allows 48 companies to combine meds supply effort.
Hunt speaks to CSL boss
Company to ensure additional flu jabs.
NPS warns on malaria drug
Drug touted as COVID 'cure' dangerous.
CWH tipped for COVID success
Retail expert predicts market share will increase.
CSL leads global COVID alliance
In TGA talks to develop, trial potential new medicine.
'Stay home' plead lung patients
Easter message with a difference from the Lung Foundation.
Top of the Hill
The future is now
COVID changes likely to stay when crisis ends.
Two targeted cancer drugs arrive
Latest from Astellas, Emerge approved by TGA.
Pharma speaks out on HCPs
What you said about rep interactions during COVID-19.
© 2003 - 2020 Lush Media
Pharma in Focus
Jolly Good Design